PND150 - IMPACT OF INOTERSEN ON CONDITION-SPECIFIC QUALITY OF LIFE (QOL) FOR PATIENTS WITH HATTR AMYLOIDOSIS- RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2898
https://www.valueinhealthjournal.com/article/S1098-3015(18)36273-9/fulltext
Title :
PND150 - IMPACT OF INOTERSEN ON CONDITION-SPECIFIC QUALITY OF LIFE (QOL) FOR PATIENTS WITH HATTR AMYLOIDOSIS- RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36273-9&doi=10.1016/j.jval.2018.09.2898
First page :
Section Title :
Open access? :
No
Section Order :
1467